Insider · CIK 0001595972
Erick Wayne DeVinney
Files at AXGN (Axogen, Inc.). First filing Mar 19, 2025, latest Mar 18, 2026.
Erick Wayne DeVinney files SEC Form 4 as officer at AXGN (Axogen, Inc.). Since Mar 19, 2025, Erick Wayne DeVinney has reported 0 open-market buys worth $0 and 4 open-market sells worth $1.1M, the latest filed on Mar 18, 2026.
A track record needs three past buys with six months of prices behind them; Erick Wayne DeVinney has 0, so none is measured yet.
The newest scored trade: sold $171k of AXGN on Mar 16, 2026, filed Mar 18, 2026, scored 11 (weak). In the last 12 months: 0 buys worth $0 and 2 sells worth $781k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AXGN: Axogen, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 11Weak | AXGNsell Axogen, Inc. | $171k 5,221 shares | -2% | +254% from low-7% from high | |
| 50Moderate | Axogen, Inc. | $609k 19,517 shares | -7% | +229% from low-8% from high | |
| 15Weak | AXGNsell Axogen, Inc. | $19k 1,137 shares | -1% | +80% from low-17% from high | |
| 13Weak | AXGNsell Axogen, Inc. | $264k 15,111 shares | -6% | - |
Transactions
Every row this insider has filed, 26 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | AXGN Axogen, Inc. | MOption exercise Common Stock | +6,363 | $0.00 | $0 | 259,297 | Mar 18, 2026 |
| Mar 16, 2026 | AXGN Axogen, Inc. | FTax withholding Common Stock | -2,870 | $32.84 | $94k | 256,427 | Mar 18, 2026 |
| Mar 16, 2026 | AXGN Axogen, Inc. | MOption exercise Common Stock | +11,575 | $0.00 | $0 | 268,002 | Mar 18, 2026 |
| Mar 16, 2026 | AXGN Axogen, Inc. | SOpen-market sale Common Stock | -5,221 | $32.84 | $171k | 262,781 | Mar 18, 2026 |
| Mar 16, 2026 | AXGN Axogen, Inc. | MOption exercise Restricted Stock Unitsderivative | +6,363 | $0.00 | $0 | 6,363 | Mar 18, 2026 |
| Mar 16, 2026 | AXGN Axogen, Inc. | MOption exercise Restricted Stock Unitsderivative | +11,575 | $0.00 | $0 | 11,575 | Mar 18, 2026 |
| Feb 26, 2026 | AXGN Axogen, Inc. | AGrant or award Common Stock | +33,780 | $0.00 | $0 | 274,912 | Mar 2, 2026 |
| Feb 26, 2026 | AXGN Axogen, Inc. | FTax withholding Common Stock | -10,702 | $31.90 | $341k | 264,210 | Mar 2, 2026 |
| Mar 1, 2026 | AXGN Axogen, Inc. | FTax withholding Common Stock | -11,276 | $30.65 | $346k | 252,934 | Mar 2, 2026 |
| Feb 26, 2026 | AXGN Axogen, Inc. | AGrant or award Restricted Stock Unitsderivative | +23,000 | $0.00 | $0 | 23,000 | Mar 2, 2026 |
| Dec 9, 2025 | AXGN Axogen, Inc. | SOpen-market sale Common Stock | -19,517 | $31.21 | $609k | 241,132 | Dec 10, 2025 |
| Dec 4, 2025 | AXGN Axogen, Inc. | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 260,649 | Dec 5, 2025 |
| Sep 13, 2025 | AXGN Axogen, Inc. | AGrant or award Common Stock | +2,500 | $0.00 | $0 | 221,786 | Sep 16, 2025 |
| Sep 16, 2025 | AXGN Axogen, Inc. | SOpen-market sale Common Stock | -1,137 | $16.29 | $19k | 220,649 | Sep 16, 2025 |
| Mar 25, 2025 | AXGN Axogen, Inc. | AGrant or award Restricted Stock Unitsderivative | +38,000 | $0.00 | $0 | 38,000 | Mar 26, 2025 |
| Mar 16, 2025 | AXGN Axogen, Inc. | MOption exercise Common Stock | +2,950 | $0.00 | $0 | 203,361 | Mar 19, 2025 |
| Mar 16, 2025 | AXGN Axogen, Inc. | MOption exercise Common Stock | +6,362 | $0.00 | $0 | 209,723 | Mar 19, 2025 |
| Mar 16, 2025 | AXGN Axogen, Inc. | MOption exercise Common Stock | +23,150 | $0.00 | $0 | 232,873 | Mar 19, 2025 |
| Mar 19, 2025 | AXGN Axogen, Inc. | SOpen-market sale Common Stock | -15,111 | $17.50 | $264k | 217,762 | Mar 19, 2025 |
| Mar 16, 2025 | AXGN Axogen, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,950 | $0.00 | $0 | 0 | Mar 19, 2025 |
| Mar 16, 2025 | AXGN Axogen, Inc. | MOption exercise Restricted Stock Unitsderivative | -6,362 | $0.00 | $0 | 6,363 | Mar 19, 2025 |
| Mar 16, 2025 | AXGN Axogen, Inc. | MOption exercise Restricted Stock Unitsderivative | -23,150 | $0.00 | $0 | 23,150 | Mar 19, 2025 |
| Feb 28, 2025 | AXGN Axogen, Inc. | MOption exercise Common Stock | +24,799 | $0.00 | $0 | 209,301 | Mar 4, 2025 |
| Mar 4, 2025 | AXGN Axogen, Inc. | FTax withholding Common Stock | -8,296 | $18.35 | $152k | 201,005 | Mar 4, 2025 |
| Feb 22, 2025 | AXGN Axogen, Inc. | AGrant or award Common Stock | +2,500 | $0.00 | $0 | 185,474 | Feb 26, 2025 |
| Feb 25, 2025 | AXGN Axogen, Inc. | FTax withholding Common Stock | -972 | $16.50 | $16k | 184,502 | Feb 26, 2025 |
Questions about Erick Wayne DeVinney
Answered from the filings on this page, as of the latest one.
Is Erick Wayne DeVinney buying or selling?
In the last 12 months Erick Wayne DeVinney reported 0 open-market buys worth $0 and 2 open-market sells worth $781k on SEC Form 4; the latest was sold $171k of AXGN on Mar 16, 2026. Grants, option exercises and tax withholding are not counted.
How did Erick Wayne DeVinney's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Erick Wayne DeVinney has 0.
Where does Erick Wayne DeVinney file Form 4?
Erick Wayne DeVinney has filed Form 4 at AXGN (Axogen, Inc.) as Chief Innovation Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.